Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

The aim of this study is to investigate the clinical efficacy and safety of ablative carbon ion radiotherapy for locally advanced unresectable pancreatic cancer with pencil beam scanning and simultaneous integrated boost (SIB) technology.

Trial Details

NCT ID
NCT05424159
Phase
NA
Sponsor
Shanghai Proton and Heavy Ion Center
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Carbon ion radiotherapy
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • Have the ability to sign the written informed consent;
  • Ductal adenocarcinoma of the pancreas confirmed by histopathology or cytopathology;
  • Distant metastasis was excluded by imaging assessment (PET-CT, cranial MRI), and was defined as locally advanced unresectable according to NCCN Gui…
  • The maximum diameter of pancreatic primary lesion and positive lymph node ≤7cm;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →